Previous Article | Next Article ![]()
Journal of Virology, August 2001, p. 7723-7726, Vol. 75, No. 16
Unité des Virus Lents, CNRS URA 1930, Institut Pasteur, 75724 Paris Cedex 15, France
Received 20 February 2001/Accepted 16 May 2001
We show that inactivating the
The DA strain of Theiler's murine
encephalomyelitis virus (TMEV), a picornavirus, is responsible for a
biphasic neurological disease of mice. The first phase is an acute
encephalomyelitis which takes place during the first 2 weeks that
follow intracerebral inoculation. During the second phase, which occurs
only in susceptible animals and is lifelong, persistent infection of
the white matter of the spinal cord causes chronic inflammation and
primary demyelination (14, 15). This natural disease is
considered one of the best models for multiple sclerosis (13,
20).
The extent of demyelination and the amount of viral RNA that persists
in the central nervous system (CNS) vary greatly among inbred mouse
strains (8). A locus with a major effect on both phenotypes has been mapped by several groups to the H-2D region of
the major histocompatibility complex (MHC) (10, 12, 17, 21,
23). This locus has been named Tmevp1 for Theiler's
murine encephalomyelitis virus persistence locus 1. Three phenotypes have been defined for the amount of viral RNA that persists in the CNS.
Resistant strains clear the infection, and their
F1 crosses with the SJL/J strain clear the
infection as well. Strains of intermediate susceptibility clear the
infection, but their F1 crosses with the SJL/J
strain do not and are infected at high levels. Finally, susceptible
strains remain persistently infected at high levels. In 15 of 16 mouse
strains examined in one study, the viral RNA load was determined by the
Tmevp1 haplotype. The H-2b
haplotype was associated with resistance, the
H-2q haplotype was associated with
susceptibility, and the H-2d,
H-2k, and
H-2s haplotypes were associated with
intermediate levels of susceptibility (10). The SJL/J
strain was the only strain which was more susceptible than predicted by
its H-2s haplotype. In subsequent work,
its susceptibility was explained by non-H-2 loci, which have
been mapped, on the mouse genome (9). Two of these loci
are located close to each other on the telomeric part of chromosome 10 (6). Interestingly, multiple susceptibility loci located
in the same region have also been reported for other phenotypes induced
by Theiler's virus infection and for other diseases.
Several observations suggest that the H-2D class I gene
explains most of the characteristics of the Tmevp1 locus
(3, 16, 22). The goal of the present work was to test if
MHC class I genes control the load of viral RNA in the SJL/J strain, a
prototypic susceptible strain with an H-2s
haplotype normally associated with intermediate susceptibility. We
examined this point using inbred SJL/J mice with an inactivated beta-microglobulin gene.
SJL/J No clinical symptoms or mortality were observed in either group of
mice. At 45 days p.i., in the spinal cord, the viral load was
significantly higher in SJL/J
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7723-7726.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Viral Load Increases in SJL/J Mice Persistently
Infected by Theiler's Virus after Inactivation of the
2m Gene
![]()
ABSTRACT
Top
Abstract
Text
References
2m gene increases the viral load of
SJL/J mice persistently infected by Theiler's virus. Together with
previous results, this shows that the characteristics of
Tmevp1, a locus which controls the amount of viral RNA that persists in the central nervous system, are those of an H-2
class I gene.
![]()
TEXT
Top
Abstract
Text
References
2m
/
mice obtained from the Jackson Laboratory (Bar Harbor, Maine) were
crossed with wild-type SJL/J mice. SJL/J mice with the three genotypes
(
2m
/
,
2m+/
, and
2m+/+) were
inoculated intracerebrally with 104 PFU of the
DA1 strain of TMEV and studied during the acute (6 days postinoculation
[p.i.]) and the chronic phase (21 and 45 days p.i.) of the
infection. DA1 is a molecularly cloned TMEV DA strain produced from the
infectious pTMDA1 plasmid (18, 19). The amount of viral
RNA in the CNS was measured by using a dot blot assay (1,
10). Briefly, for each mouse, fivefold dilutions of total RNA
were dotted onto a filter and hybridized with either a viral cDNA probe
or a control
-actin probe. The hybridized filters were analyzed with
a phosphorimager. The highest dilution which gave a positive signal was
used as a measure of viral RNA content (see Fig. 1 of reference
7). To normalize the results between experiments,
dilutions of reference RNA samples were dotted onto each filter. The
means of viral RNA content for mice with the three genotypes were
compared by using analysis of variance, and two-tail comparisons were
performed by using Scheffé's test. Viral antigens were detected
in CNS sections by immunocytochemistry (2).
2m
/
mice
(m
2m
/
= 3.6 ± 0.1 [n = 15]) than in SJL/J
2m+/+ mice
(m
2m+/+ = 2.2 ± 0.4 [n = 17]) (P = 0.0099).
SJL/J
2m+/
mice had an intermediate phenotype
(m
2m+/
= 2.8 ± 0.3 [n = 19]) (Fig.
1C). As determined by
immunocytochemistry, the virus was localized in the white matter of
spinal cord, often close to the border with the gray matter, in mice
with the three genotypes (Fig. 2). A
large number of infected cells were observed in the five SJL/J
2m
/
and five
SJL/J
2m+/
mice examined. In contrast, only low numbers of infected cells were
detected in SJL/J
2m+/+ mice and only
in four of seven animals. The extent of inflammation (meningitis,
perivascular cuffs, and diffuse parenchymal infiltration) correlated
with the number of infected cells. In conclusion, the SJL/J
2m
/
mice are
more susceptible to viral persistence than wild-type SJL/J mice. SJL/J
2m+/
mice have
an intermediate phenotype. Viral localization within the CNS is the
same for the three groups of mice.

View larger version (20K):
[in a new window]
FIG. 1.
Amount of viral RNA in the CNSs of mice with the
wild-type SJL/J, SJL/J
2m+/
and
SJL
2m
/
genotypes. Mice were
examined at 6 days p.i. (A), 21 days p.i. (B), and 45 days p.i. (C).
The amount of viral RNA is expressed as the highest RNA dilution which
gave a hybridization signal in a dot blot assay. The left
y axis shows the amount of viral DNA as a dilution
factor, whereas the right y axis shows the amount of
viral DNA as a score which corresponds to the dilution number in the
series. Open bars, spinal cord; solid bars, brain. n, number of animals
per group.

View larger version (89K):
[in a new window]
FIG. 2.
Detection of viral antigens at 45 days p.i. in
longitudinal sections of white matter from the spinal cords of
wild-type SJL/J (A) and SJL/J
2m
/
(B) mice.
Viral antigens were detected by immunoperoxidase. Sections were
counterstained with hematoxylin. Arrows point to cells containing viral
antigens. Magnification, ×200.
To evaluate the effect of the
2m
/
mutation
on the early phases of the infection, the load of viral RNA and
histopathology were examined in brain and spinal cord at 6 and 21 days
p.i. At 6 days p.i., no significant difference in the load of viral RNA was detected among the three groups of mice, in brain
(P = 0.1476) as well as in spinal cord
(P = 0.1622) (Fig. 1A). Histological studies showed
viral antigens mainly in the cortex and hippocampus in three of six
wild-type SJL/J mice, five of six SJL/J
2m+/
mice,
and both SJL/J
2m
/
mice
examined. Infection was associated with perivascular cuffs and
parenchymal inflammation (data not shown). At 21 days p.i., the amount
of viral RNA in brain was significantly higher in SJL/J
2m+/
(m
2m+/
= 1.0 ± 0.1 [n = 22],
P < 0.001) and SJL/J
2m
/
mice
(m
2m
/
= 1.6 ± 0.2 [n = 10],
P < 0.0001) than in SJL/J
2m+/+ mice
(m
2m+/+ = 0 ± 0 [n = 16] (Fig. 1B). No significant differences in the
viral RNA load in the spinal cord were observed for mice of the
different genotypes (P = 0.2976). Histological
examination confirmed that by 21 days p.i., the virus had infected the
white matter of the spinal cord for the three groups of mice. The viral
RNA loads in the brains were significantly lower at 21 days p.i. than
at 6 days p.i. regardless of the SJL/J genotypes (P < 0.0001). On the other hand, the amount of viral RNA in the spinal cord
increased significantly between 6 and 21 days p.i. (P = 0.0151) but only slightly, and not significantly, between 21 and 45 days p.i. (P = 0.2152). This increase was independent of the genotype. In summary, these experiments show that SJL/J
2m
/
and SJL/J
2m+/
mice are
more susceptible to persistent infection of the white matter of spinal
cord than wild-type SJL/J mice. They also show that the differences in
viral RNA load become significant only at the onset of the chronic
phase of the disease.
In conclusion, our results show that MHC class I genes control the amount of viral RNA that persists in the CNS even in a highly susceptible strain, such as the SJL/J strain. The Tmevp1 locus has three major characteristics. First, it is located in the H-2D region of the MHC. Second, the resistant H-2b haplotype is dominant. Third, mice with Tmevp1 haplotypes of intermediate susceptibility control the viral RNA load to some extent. All these characteristics could be those of an H-2 class I gene. Indeed, the H-2Db gene, not the H-2Kb gene, confers resistance to persistent infection, which agrees with the H-2D localization of Tmevp1 (4, 5). Susceptible mice transgenic for the H-2Db gene become resistant, which is consistent with the resistant haplotype of Tmevp1 being dominant (3). Last, the present data show that mice with a Tmevp1 haplotype associated with intermediate susceptibility control the persisting viral RNA load through a class I-restricted mechanism. Therefore, TMEV persistence appears to be under the control of a single MHC-linked locus, Tmevp1, which has all the characteristics of an H-2 class I gene. Interestingly, for experimental autoimmune encephalomyelitis, which is another model of multiple sclerosis, several H-2 loci have been implicated in genetic control of the disease (11).
| |
ACKNOWLEDGMENTS |
|---|
We thank M. Gau for secretarial assistance.
This work was supported in part by grants from the Institut Pasteur Fondation, the Centre National de la Recherche Scientifique, the Association pour la Recherche sur la Sclérose en Plaques, and the National Multiple Sclerosis Society. S.A. is a recipient of a scholarship from the Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Unité des Virus Lents, CNRS URA 1930, Institut Pasteur, 28, rue du Dr. Roux, 75724 Paris Cedex 15, France. Phone: (33-1) 40 61 33 25. Fax: (33-1) 40 61 31 67. E-mail: jfb{at}pasteur.fr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Aubagnac, S.,
M. Brahic, and J.-F. Bureau.
1999.
Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus.
J. Virol.
73:7965-7971 |
| 2. | Aubert, C., M. Chamorro, and M. Brahic. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3:319-326[CrossRef][Medline]. |
| 3. |
Azoulay, A.,
M. Brahic, and J.-F. Bureau.
1994.
FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.
J. Virol.
68:4049-4052 |
| 4. |
Azoulay-Cayla, A.,
S. Dethlefs,
B. Pérarnau,
E.-L. Larsson-Sciard,
F. A. Lemonnier,
M. Brahic, and J.-F. Bureau.
2000.
H-2Db / mice are susceptible to persistent infection by Theiler's virus.
J. Virol.
74:5470-5476 |
| 5. |
Azoulay-Cayla, A.,
S. Syan,
M. Brahic, and J. F. Bureau.
2001.
Roles of the H-2Db and H-2Kb genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system.
J. Gen. Virol.
82:1043-1047 |
| 6. |
Bihl, F.,
M. Brahic, and J.-F. Bureau.
1999.
Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system.
Genetics
152:385-392 |
| 7. | Bihl, F., C. Pena-Rossi, J.-L. Guénet, M. Brahic, and J.-F. Bureau. 1997. The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J. Virol. 71:5025-5030[Abstract]. |
| 8. | Brahic, M., and J.-F. Bureau. 1998. Genetics of susceptibility to Theiler's virus infection. Bioessays 20:627-633[CrossRef][Medline]. |
| 9. | Bureau, J.-F., X. Montagutelli, F. Bihl, S. Lefebvre, J.-L. Guénet, and M. Brahic. 1993. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:87-91[CrossRef][Medline]. |
| 10. |
Bureau, J.-F.,
X. Montagutelli,
S. Lefebvre,
J.-L. Guénet,
M. Pla, and M. Brahic.
1992.
The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.
J. Virol.
66:4698-4704 |
| 11. |
Butterfield, R. J.,
J. D. Sudweeks,
E. P. Blankenhorn,
R. Korngold,
J. C. Marini,
J. A. Todd,
R. J. Roper, and C. Teuscher.
1998.
New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice.
J. Immunol.
161:1860-1867 |
| 12. | Clatch, R. J., R. W. Melvold, S. D. Miller, and H. L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV) induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV specific delayed-type hypersensitivity. J. Immunol. 135:1408-1413[Abstract]. |
| 13. | Dal Canto, M. C., and H. L. Lipton. 1977. Multiple sclerosis: animal model of human disease. Theiler's virus infection in mice. Am. J. Pathol. 88:497-500[Medline]. |
| 14. |
Lipton, H. L.
1975.
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.
Infect. Immun.
11:1147-1155 |
| 15. |
Lipton, H. L.,
J. Kratochvil,
P. Sethi, and M. C. Dal Canto.
1984.
Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection.
Neurology
34:1117-1119 |
| 16. | Lipton, H. L., R. Melvold, S. D. Miller, and M. C. Dal Canto. 1995. Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. J. Neurovirol. 1:138-144[Medline]. |
| 17. | Lipton, H. L., and R. W. Melvold. 1984. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132:1821-1825[Abstract]. |
| 18. | McAllister, A., F. Tangy, C. Aubert, and M. Brahic. 1989. Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb. Pathog. 7:381-388[CrossRef][Medline]. |
| 19. | Michiels, T., V. Dejong, R. Rodrigus, and C. Shaw-Jackson. 1997. Protein 2A is not required for Theiler's virus replication. J. Virol. 71:9549-9556[Abstract]. |
| 20. | Monteyne, P., J.-F. Bureau, and M. Brahic. 1997. The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 159:163-176[CrossRef][Medline]. |
| 21. | Rodriguez, M., and C. S. David. 1985. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:2145-2148[Abstract]. |
| 22. | Rodriguez, M., and C. S. David. 1995. H-2Dd transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1:111-117[Medline]. |
| 23. |
Rodriguez, M.,
J. L. Leibowitz, and C. S. David.
1986.
Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.
J. Exp. Med.
163:620-631 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»